FIELD: chemistry.
SUBSTANCE: present invention relates to a new cannabiguerol quinone derivative of formula (I) or its pharmaceutically acceptable salt used for treating PPARg-related diseases, as well as compositions containing it. In the Formula, IR represents a carbon atom of a group represented by: aryl, linear or branched alkenyl, linear or branched alkynyl or linear or branched alkoxycarbonyl; or where R is a nitrogen atom of a linear or branched group represented by: linear or branched alkylamino, arylamino, linear or branched alkenylamino or linear or branched alkynylamino; or, alternatively, R is bond between 2 molecules of Formula (I), forming a dimer.
EFFECT: treating PPARg-related diseases.
4 cl, 13 dwg, 2 tbl, 10 ex
Title | Year | Author | Number |
---|---|---|---|
NEW CANNABIDIOL QUINONE DERIVATIVES | 2014 |
|
RU2667504C2 |
HYDROXYPURINE COMPOUNDS AND USE THEREOF | 2016 |
|
RU2685417C1 |
MACROCYCLIC COMPOUND AND ITS USE | 2019 |
|
RU2798235C2 |
METHOD FOR PREPARING RETINAL OR ADDUCT (COMPLETE-E)-RETINAL WITH HYDROQUINONE AND INTERMEDIATE SUBSTANCES | 2002 |
|
RU2318805C2 |
NOVEL OPTICALLY ACTIVE 4-HYDROXY-2-AZA-9,10-ANTHRAQUINONES, HAVING ANTIINFLAMMATORY ACTIVITY, AND SYNTHESIS METHOD THEREOF | 2010 |
|
RU2436775C1 |
HYDROXYPYRIDOXAZEPINES AS Nrf2 ACTIVATORS | 2020 |
|
RU2812931C2 |
SUBSTITUTED BENZENE COMPOUNDS | 2013 |
|
RU2658919C2 |
DERIVATIVES OF PYRAZOLO(3,4-B)PYRIDINE | 1989 |
|
RU2022964C1 |
COMPOUNDS - SULFAMATE DERIVATIVES FOR USE IN TREATING OR RELIEVING PAIN | 2014 |
|
RU2699025C1 |
THERAPEUTIC QUINONES | 2005 |
|
RU2411229C2 |
Authors
Dates
2019-04-16—Published
2015-02-12—Filed